Biogen (BIIB)

R&D Expense Growth

-21.45%

Fiscal year · Period ending:

BIIB logo

BIIB R&D Expense Growth

Latest reported-21.45%
BIIB FY R&D Growth (YoY) (0.00% → -21.45%)
High-resolution chart · PNG

BIIB r&d expense growth history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Biogen R&D Expense Growth — Annual fiscal periods
Period endingR&D Expense Growth
-21.4507%
-7.922%
4.0662%
-23.6289%
-24.9454%
63.5337%
2.2438%
14.1599%
20.2858%
-1.9624%
6.3061%
30.0591%
5.5984%
13.0384%
-2.3228%
-2.6861%
19.6827%
15.8776%
28.783%
-3.9163%
9.0103%
-35.0707%
947.2469%
-67.9332%
3.8687%
36.9369%
24.7845%
21.8053%
9.9083%
51.386%
-4.1277%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.